Clinical Trial Update: Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

This Clinical Trial Update reports on a Phase 1 study evaluating the combination of panobinostat (LBH589) and imatinib mesylate in patients with previously trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)
• Panobinostat (Panobinostat)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED